An Open-Label Trial Measuring Satisfaction And Convenience Of Two Formulations Of Lamotrigine In Subjects With A Mood Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

97

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions
Mood Disorders
Interventions
DRUG

Lamotrigine

Experimental formulation

Trial Locations (18)

14760

GSK Investigational Site, Olean

23505

GSK Investigational Site, Norfolk

25301

GSK Investigational Site, Charleston

27609

GSK Investigational Site, Raleigh

30060

GSK Investigational Site, Marietta

32257

GSK Investigational Site, Jacksonville

32763

GSK Investigational Site, Orange City

32792

GSK Investigational Site, Winter Park

44106

GSK Investigational Site, Cleveland

45243

GSK Investigational Site, Cincinnati

55454

GSK Investigational Site, Minneapolis

62208

GSK Investigational Site, Fairview Heights

63301

GSK Investigational Site, Saint Charles

76012

GSK Investigational Site, Arlington

77014

GSK Investigational Site, Houston

77042

GSK Investigational Site, Houston

92108

GSK Investigational Site, San Diego

92705

GSK Investigational Site, Santa Ana

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY